Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.000
+0.059 (6.26%)
At close: Nov 5, 2024, 4:00 PM
1.010
+0.010 (1.00%)
After-hours: Nov 5, 2024, 5:20 PM EST

Tempest Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-31.75-29.49-35.71-28.3-19.21-14.37
Depreciation & Amortization
0.420.380.640.370.340.1
Stock-Based Compensation
4.32.551.561.110.450.31
Other Operating Activities
1.841.881.571.480.47-8.3
Change in Accounts Payable
0.49-0.260-0.21-0.570.95
Change in Other Net Operating Assets
-0.65-2.410.87-0.4-0.5-0.26
Operating Cash Flow
-25.36-27.36-31.07-25.96-19.02-21.56
Capital Expenditures
-0.42-0.17-0.56-0.14-0.05-1.36
Other Investing Activities
---0.040.04-
Investing Cash Flow
-0.42-0.17-0.56-0.1-0.01-1.36
Long-Term Debt Issued
---15--
Long-Term Debt Repaid
---4.74---
Net Debt Issued (Repaid)
---4.7415--
Issuance of Common Stock
39.3835.68.8633.530.070.04
Other Financing Activities
--7.2810.53-0.47-0.04
Financing Cash Flow
39.3835.611.459.0634.623
Net Cash Flow
13.68.08-20.2333.0115.580.08
Free Cash Flow
-25.78-27.53-31.63-26.09-19.07-22.92
Free Cash Flow Per Share
-1.31-1.79-2.74-6.88-40.73-27.34
Cash Interest Paid
1.31.251.540.95--
Cash Income Tax Paid
0.090.190.02--0
Levered Free Cash Flow
-15.2-17.47-18.33-16.38-12.89-
Unlevered Free Cash Flow
-14.27-16.57-17.32-15.58-12.89-
Change in Net Working Capital
-1.231.1-2.690.061.57-
Source: S&P Capital IQ. Standard template. Financial Sources.